GMO Labeling Bill Passes Senate, Headed For House Vote

The U.S. Senate has approved a controversial bill which would create a federal standard for labeling foods that contain genetically engineered or modified ingredients.

According to a recent poll, approximately 93% of all Americans support GMO labeling. (Photo: CT Senate Democrats/ cc/ Flickr)

On Thursday, the U.S. Senate approved the “Agriculture Biotechnology Solution” bill  which will require foods containing genetically modified ingredients to be labeled with words, pictures, or a QR code that must be scanned by a smartphone. The Senate voted 63 to 30 to approve the bill after a controversial cloture vote on Wednesday. The bill will

¡ Sea sociable, comparta!

Bernie Sanders Just Blocked Obama’s Nominee To Head FDA over Ties to Big Pharma

“Dr. Califf’s extensive ties to the pharmaceutical industry give me no reason to believe that he would make the FDA work for ordinary Americans, rather than just the CEOs of pharmaceutical companies.”

Democratic presidential candidate, Sen. Bernie Sanders, I-Vt, speaks during a campaign rally in Springfield, Mass., Saturday, Oct. 3, 2105. (AP Photo/Michael Dwyer)

Senator Bernie Sanders put a hold on President Barack Obama’s nominee to take over the Food and Drug Administration (FDA) on Tuesday, joining with two other senators who have also objected to Dr. Robert M. Califf’s nomination, citing his ties to corporate drug manufacturers. “Dr. Califf’s extensive ties to the pharmaceutical industry give me no

¡ Sea sociable, comparta!

Obama’s New Appointee To Head The FDA Is A Big Pharma Mega-Lobbyist

While at Duke, Robert M. Califf received millions in funding and salary support from Eli Lilly, Merck, Novartis, and other drug companies.

While at Duke, Robert M. Califf received millions in funding and salary support from Eli Lilly, Merck, Novartis, and other drug companies.

(ANTIMEDIA) President Obama’s recent nominee to chair the Food and Drug Administration has drawn harsh criticism for his ties to the pharmaceutical industry. The disapproval grew more justified this week as it was revealed that until this year, nominee Dr. Robert Califf was a board member and consultant for a company whose sole purpose is to help

¡ Sea sociable, comparta!

Ecstasy May Soon Be A Treatment For Social Anxiety Among Autistic Adults

Researchers are set to study the therapeutic effects of MDMA in what will be the first assessment of the active component of the street drug Ecstasy, for social anxiety in autistic adults

Ecstasy MDMA pills

Researchers are planning the first pilot study of MDMA-assisted therapy for the treatment of social anxiety in autistic adults. In a recent review in press in the journal, Progress in Neuro-Psychopharmacology & Biological Psychiatry, a team of researchers led by Alicia Danforth, laid out their proposed methods and study rationale for what

¡ Sea sociable, comparta!

Election Day Could Make Or Break GMO Labeling Initiatives

The health impacts of GMOs are debatable, but the economic stakes are enormous. With mandatory GMO labeling referenda on the ballots in two states on Tuesday, voters will decide who sets the terms on their right to know what’s in their food: processors or themselves.

Prop 37 Food Labeling

WASHINGTON --- With a series of state-level victories and losses under their belts, supporters of labeling requirements for certain foods made with genetically modified ingredients are looking at Tuesday’s election as a potential tipping point. State referenda on the issue are on this year’s ballots in two states, Oregon and Colorado. Passage in

¡ Sea sociable, comparta!

Birth Defects: A Possible Side Effect Of FDA Proposal On A Natural B Vitamin

The shift to putting “folic acid” on supplement labels could potentially increase birth defects, allow a pharmaceutical company to rake in much more money and ultimately leave many people unable to absorb the compound they’re hoping to benefit from consuming.

Pills

WASHINGTON -- An essential “B” vitamin which prevents certain birth defects and helps adults with a host of medical problems would disappear from the vitamin market under an inexplicable Food and Drug Administration labeling proposal that’s drawing fierce opposition from many quarters. The vitamin at issue is B 9 – a group of compounds known

¡ Sea sociable, comparta!